Latest Articles

Publication Date
All News Scientific
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Read Full Article
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive

Published: Feb. 5, 2025, 5:17 p.m.
Read Full Article
A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting - Cureus

A Case of Postoperative Lymphatic Ascites in Endometrial Cancer Spontaneously Resolving After Approximately One Year of Watchful Waiting Cureus

Published: Feb. 5, 2025, 1:26 p.m.
Read Full Article
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.
Read Full Article
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com

Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com

Published: Feb. 5, 2025, 11:37 a.m.
Read Full Article
Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion? - bmcwomenshealth.biomedcentral.com

Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion? bmcwomenshealth.biomedcentral.com

Published: Feb. 5, 2025, 6:49 a.m.
Read Full Article
Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion? - BioMed Central

Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion? BioMed Central

Published: Feb. 5, 2025, 6:49 a.m.
Read Full Article
Endometrial Ablation Devices Market Poised for Strong Growth, Projected to Reach $5.13 Billion by 2029 with... - WhaTech

Endometrial Ablation Devices Market Poised for Strong Growth, Projected to Reach $5.13 Billion by 2029 with... WhaTech

Published: Feb. 5, 2025, 5:59 a.m.
Read Full Article
Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab - Physician's Weekly

Survival Outcomes in Advanced Endometrial Cancer with Lenvatinib plus Pembrolizumab Physician's Weekly

Published: Feb. 4, 2025, 11:09 a.m.
Read Full Article
The qualitative and quantitative characteristics of serous endometrial carcinoma on MRI: applying a novel nomogram for predicting an aggressive histological type - Frontiers

The qualitative and quantitative characteristics of serous endometrial carcinoma on MRI: applying a novel nomogram for predicting an aggressive histological type Frontiers

Published: Feb. 3, 2025, 10:27 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!